Serum biochemical indicators of hepatobiliary function in dogs following prolonged anaesthesia with sevoflurane or isoflurane.

OBJECTIVE To investigate the changes in serum enzymes considered as biochemical indicators of hepatobiliary function in dogs following 5 hours of anaesthesia with isoflurane (ISO) or sevoflurane (SEVO). STUDY DESIGN Experimental randomized crossover study, with intervals of at least 15 days between successive treatments. ANIMALS Eight healthy adult mongrel dogs, four male, four female, weight 13.6-21.6 kg. METHODS Treatments consisted of anaesthesia with ISO or SEVO at 1 or 1.5 minimum alveolar concentration (MAC) delivered in oxygen. MAC was taken as 1.39% for ISO and 2.36% for SEVO. Anaesthesia was induced by mask then, after endotracheal intubation, maintained according to the treatment protocol using a small animal circle system. Cardiopulmonary monitoring was carried out. Venous blood samples, obtained by needle puncture, were taken at 24 hours and 2, 7 and 14 days post anaesthesia. Serum concentrations of total protein, aspartate aminotransferase (AST), alanine aminotransferase (ALT), lactate dehydrogenase, (LDH), alkaline phosphatase (ALP), gamma-glutamyltransferese and total bilirubin were measured. Changes with time and with treatment were compared by Friedman analysis, Wilcoxon Signed test and Kruskal-Wallis test as relevant. p- value < 0.05 was considered significant. RESULTS Compared to base-line values, at 24 hours post-anaesthesia there were significant increases in AST, ALT, ALP and LDH following one or more of the treatments, but by 2 days residual changes were not significant. At 24 hours, AST for treatment 1.5 MAC ISO was higher than 1 MAC ISO (p < 0.002), and LDH higher for 1.5 MAC SEVO than 1 MAC SEVO. CONCLUSION AND CLINICAL RELEVANCE Both ISO and SEVO, at concentrations used for clinical anaesthesia, produce transient moderate effects on some hepatobiliary enzyme concentrations in dogs.

[1]  S. Singhal,et al.  Sevoflurane hepatotoxicity: a case report of sevoflurane hepatic necrosis and review of the literature. , 2010, American journal of therapeutics.

[2]  E. Kharasch Adverse Drug Reactions With Halogenated Anesthetics , 2008, Clinical pharmacology and therapeutics.

[3]  S. Luna,et al.  A study of the effect of hemorrhage on the cardiorespiratory actions of halothane, isoflurane and sevoflurane in the dog. , 2007, Veterinary anaesthesia and analgesia.

[4]  O. Yuge,,et al.  A Comparison of the Effects of Prolonged (>10 Hour) Low-flow Sevoflurane, High-flow Sevoflurane, and Low-flow Isoflurane Anaesthesia on Hepatorenal Function in Orthopaedic Patients , 2004, Anaesthesia and intensive care.

[5]  A. Topal,et al.  Hepatic effects of halothane, isoflurane or sevoflurane anaesthesia in dogs. , 2003, Journal of veterinary medicine. A, Physiology, pathology, clinical medicine.

[6]  T. Beringer,et al.  Fatal hepatotoxicity after re-exposure to isoflurane: a case report and review of the literature. , 2000, European journal of gastroenterology & hepatology.

[7]  K. Hanaoka,et al.  Liver function after sevoflurane or isoflurane anaesthesia in neurosurgical patients , 1998, Canadian journal of anaesthesia = Journal canadien d'anesthesie.

[8]  K. Hanaoka,et al.  Liver and renal function after repeated sevoflurane or isoflurane anaesthesia , 1998, Canadian journal of anaesthesia = Journal canadien d'anesthesie.

[9]  S. Dial Clinicopathologic evaluation of the liver. , 1995, The Veterinary clinics of North America. Small animal practice.

[10]  P. Conzen,et al.  The effects of sevoflurane, halothane, enflurane, and isoflurane on hepatic blood flow and oxygenation in chronically instrumented greyhound dogs. , 1992, Anesthesiology.